Sovaldi Evaluated With Different NS5A Inhibitors In HCV/HIV Patients
Executive Summary
Both combos outperform previous HCV regimens in co-infected patients, however, the tandem of sofosbuvir and daclatasvir may offer better efficacy for black patients than the Harvoni fixed-dose combo.